З 06 по 07 червня 2014 року у Нордвіку (Нідерланди) відбулася  щорічна нарада керівників національних урологічних асоціацій під егідою Європейської асоціації урологів ( EAU National Societies Meeting)

Засідання проходили в сучасному конференс - центрі  отелю Оранж  у Нордвіку (Нідерланди) Address:

• Hotels van Oranje
• Koningin Wilhelminaboulevard 20-31
• 2202 GV Noordwijk
• The Netherlands
• Phone: +31 71 367 68 69
• www.hotelsvanoranje.nl          

Употребление экстракта зеленого чая ослабляет воспалительную реакцию при бактериальном цистите. К такому выводу пришли ученые отделений урологии и патологии университетской клиники «Хадасса» в Иерусалиме.

Государственная программа постепенного повышения зарплат бюджетников до 2018 года была принята в 2012 году, ее главная цель – перевод всех бюджетников на систему эффективных контрактов. Данная система предполагает, что зарплата всех работников бюджетной сферы будет зависеть от сложности и качества оказываемых услуг.

On 21-22 November 2014, the 1st Joint Meeting of the EAU Section of Genito-Urinary Reconstructive Surgeons (ESGURS) and the European Society for Paediatric Urology (ESPU) will take place in Ghent, Belgium.

​

Call for Papers and Participation

The Athens Institute for Education and Research (ATINER) organizes its 3rd Annual International Conference on Health & Medical Sciences, 4-7 May 2015, Athens, Greece. The conference website is: http://www.atiner.gr/healthsciences.htm.

The aim of the conference is to bring together scholars, researchers and students from all areas of health sciences, medical sciences and related disciplines.

Fee structure information is available on www.atiner.gr/fees.htm.

В мае 2014 года в Москве прошла Ежегодная неделя мужского здоровья. Ее открыл Всероссийский интерактивный урологический форум, посвященный актуальным проблемам урологии и современным способам лечения эректильной дисфункции и нарушений мочеиспускания у пациентов с аденомой предстательной железы.

По статистике, у двух абсолютно здоровых людей разного пола при регулярных сексуальных контактах шанс зачать ребенка равен всего 20 %. Учеными было обнаружено, что в данном процессе важную роль играют белки с определенными свойствами. Именно они были обнаружены учеными из больницы Маунт-Синай в Нью-Йорке и британского института Сенгера. Результаты исследования были опубликованы в журнале Nature.

Министерство здравоохранения намерено ввести в российских больницах новые должности – врачей-стажеров и врачей-помощников – с целью дать возможность интернам и ординаторам улучшить свое материальное положение.

На сегодняшний день врачи, обучающиеся в ординатуре или интернатуре, могут рассчитывать только на собственную стипендию, размер которой в среднем составляет прожиточный минимум. Это связано с новой редакцией Закона РФ «Об образовании». Поэтому Минздрав с целью помочь поправить материальное положение врачам-интернам и ординаторам планирует разрешить им занимать должности в государственных медицинских учреждениях.

Несмотря на изменение порядка финансирования работы высокотехнологичных медицинских центров, их пациенты будут получать необходимую помощь в полном объеме. Об этом заявил Председатель Правительства РФ Дмитрий Медведев во время выступления с отчетом Правительства в Госдуме.

Напомним, что в декабре прошлого года был утвержден перечень видов высокотехнологичной помощи и более четко определено финансирование федеральных медицинских центров за счет федерального и региональных бюджетов и средств Фонда обязательного медицинского страхования (ФОМС). В конце февраля нынешнего года Президент Владимир Путин заверил, что крупные лечебно-научные центры остаются на федеральном уровне, а объем высокотехнологичной медицинской помощи необходимо увеличивать. Минздрав получил поручение подготовить доклад о порядке финансирования федеральных медучреждений. Но в конце марта в Минздрав поступил официальный запрос, почему документ, определяющий механизм финансирования центров из бюджета ФОМС, еще не готов.

SALT LAKE CITY, Utah, May 1, 2014 - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced clinical data from three studies on Prolaris in prostate cancer patients will be featured at the 2014 American Urological Association (AUA) Annual Meeting, being held May 16-21, 2014, in Orlando, Fla. Prolaris is a novel molecular diagnostic test that accurately predicts cancer-specific death and metastases in men with prostate cancer and is a stronger indicator of clinical outcomes than Gleason score or PSA. In clinical practice, Prolaris is the only test to demonstrate that physicians changed their treatment plans in 65 percent of cases after receiving the test report - 40 percent of patients had a reduction in therapeutic burden, while 25 percent had an increase in therapeutic burden.

At the AUA annual meeting, new data will be presented from the largest clinical validation study to date of any gene-based prognostic test in patients with prostate cancer diagnosed from biopsy. In the second study to be presented, the data will show that the Prolaris test significantly outperformed the current procedure of upgrading to Gleason 3+4 or 4+3 in predicting biochemical recurrence after a radical prostatectomy. The third study will show the prognostic utility of Prolaris based on needle biopsy samples. These studies add to the growing body of outcomes data for Prolaris, which has been extensively validated in 11 clinical studies and more than 5,000 patients. Myriad also will present new data from an investigational diagnostic test for patients with renal cell carcinoma.

“More than ever, we are committed to developing novel molecular diagnostic tests to help to improve patient outcomes, survival and quality of life for people living with prostate and renal cancers,” said Michael Brawer, M.D., vice president of Medical Affairs at Myriad. “Our Prolaris test is rapidly becoming the leading test to help the 240,000 men diagnosed with prostate cancer each year to determine if they have aggressive prostate cancer or not. We’re also actively developing a new prognostic test for renal cell cancer, which affects 60,000 people every year.”

Panel addresses success of antibiotic prophylaxis for preventing febrile UTI as well as the impact of the American Academy of Pediatrics UTI 2011 Guidelines for diagnosing and managing febrile UTI in Children with VUR

Orlando, FL, May 18, 2014 — Two studies evaluating widely-used practices to prevent, diagnose and manage febrile urinary tract infections (UTI) in children with vesicoureteral reflux (VUR) will be presented at the 109Ih Annual Scientific Meeting of the American Urological Association (AUA). The joint press conference will be held at the Orange County Convention Center in Orlando, FL on Sunday, May 18 at 8:30 a.m. ET.

Many children develop UTIs. Some children are more prone to these infections than others and may develop recurrent UTIs, which in most cases, are treated with antibiotics. Children with febrile UTIs (infected urine that travels into the upper urinary tract and the kidneys resulting in fever) may have an underlying problem with their urinary tract, making it more likely for them to experience a serious infection. The most common underlying problem is VUR, which is an abnormality in the connection between the bladder and one or both of the ureters. Affecting approximately one percent of all children, those with VUR are often treated with antibiotics to prevent febrile UTI; however a recent study suggests antibiotics may not reduce the chance of febrile UTI in children.

In a separate study, which looked at the practice parameters for diagnosing and managing febrile UTI in children, it reveals the 2011 American Academy of Pediatrics (AAP) Guideline, "Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months" has positively impacted the treatment and management of infants and young children brought into an emergency room with symptoms of febrile UTI.

Panel discusses changes in a man's sexual function after a bilateral nerve-sparing radical prostatectomy
and in those with LUTS/BPH

Orlando, FL, May 18, 2014 — Two studies evaluating the sexual function in men with Lower Urinary Tract Symptoms (LUTS) as well as post bilateral nerve-sparing radical prostatectomy will be presented to the media at a special press conference during the 2014 Annual Scientific Meeting of the American Urological Association (AUA). Tobias S. Kohler, MD, MPH, FACS; associate professor & residency program director with Southern Illinois University School of Medicine will moderate the session, which will take place on Sunday, May 18, 2014 at 2:00 p.m. ET, in the Orange County Convention Center.
Study Details

Tadalafil Once a Day Significantly Reduces Penile Length-Loss in Patients Post Bilateral Nerve-Sparing Radical Prostatectomy - Results from a Randomized Controlled Trial (#MP48-10): Erectile dysfunction following radical prostatectomy for clinically localized prostate cancer is a known side effect to the surgery; however with the introduction of the nerve-sparing radical prostatectomy technique, many men can expect to recover erectile function, but early recovery of natural erectile function is not common. Increasing attention has been given to this concern in recent years and is why researchers from Canada, the United States and five European countries compared the efficacy and protective effect of Tadalafil (a phosphodiesterase type 5 inhibitor approved to treat erectile dysfunction), on penile function after nerve sparing radical prostatectomy.

Orlando, FL, May 18, 2014 - With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection, according to a new study at the 109,h Annual Scientific Meeting of the American Urological Association (AUA). The study will be presented to the media during a special press conference on Friday, May 18 at 1:00 p.m. at the Orlando County Convention Center. Brian Stork, MD, urologist, West Shore Urology, Muskegon, Ml will moderate the media session.

It has long been known that dogs have a stronger sense of smell than humans. While humans have roughly five million olfactory cells in their noses, dogs have about 200 million. For years, law enforcement and the military have used dogs to them help locate bombs and drugs. It should then be no surprise that a dog's intricate sense of smell has also captured the interest of the medical world. In recent years, new findings have emerged to indicate dogs are capable of detecting the onset of epileptic seizures as well as malignancies of the breast and lung. In 2010, research emerged demonstrating a dog's ability to "sniff out" prostate cancer; however the study was relatively small with 33 patients. This study, however addresses the ability of canines to accurately detect the presence of prostate cancer in a much larger cohort.

Assessment of sperm quality suggests no association with congenital anomalies

Orlando, FL, May 18, 2014 — Birth defects do not appear to be associated with the father's semen quality, according to a new study at the 109,hAnnual Scientific Meeting of the American Urological Association (AUA), The study, conducted by researchers from Baylor College of Medicine, Stanford University and the Texas Department of State Health Services, will be presented to reporters during a special press conference at the Orange County Convention Center, Orlando, FL on Sunday, May 18 at 9:45 a m. ET.

Orlando, FL, May 16, 2014 - Airbags and seat belts not only protect people from head and chest injuries during car accidents, they may also protect the kidneys, according to a new study at the 109th Annual Scientific Meeting of the American Urological Association (AUA). The study will be presented to the media during a special press conference on Friday, May 16 at 10:30 a.m. at the Orlando County Convention Center. This session will be moderated by AUA past President Jack W. McAninch, MD, professor of urology at the University of California, San Francisco.

Data Presented at AUA Shows Prolaris Outperforms Antiquated Upgrading Practice

SALT LAKE CITY, Utah, May 20, 2014 - Myriad Genetics, Inc. (NASDAQ: MYGN) today presented new data from a clinical validation study of Prolaris at the 2014 American Urological Association (AUA) Annual Meeting in Orlando, Fla. The study is the largest validation study to date of any gene-based prognostic test in patients with prostate cancer who were diagnosed by needle biopsy. A key finding was that the Prolaris test accurately differentiated newly diagnosed patients who were likely to die from prostate cancer within 10 years from those with lower-risk disease, which should open the door to more appropriate clinical care for patients at all risk levels. Prolaris is a novel molecular diagnostic test that accurately predicts cancer-specific death and metastases in men with prostate cancer and is a much stronger indicator of clinical outcomes than Gleason score or PSA.

Orlando, FL, May 18, 2014 — Three new studies examining the predictors, effects and durability of testosterone therapy on men will be presented to reporters at the 109th Annual Scientific Meeting of the American Urological Association (AUA) during a special press conference in the Orange County Convention Center, Orlando, FL on Sunday, May 18 at 2:00 p.m. ET.
Testosterone, a hormone produced primarily in the testicles, helps maintain a man's:

З 16 по 21 05.2014 року у Орландо (США) відбувся традиційний, щорічний з’їзд Американської асоціації урологів. Наукові сесії проходили в сучасному конгрес-центрі Орландо.

В ходе конференции CNews «ИКТ в госсекторе — 2014»  заместитель директора департамента информационных технологий и связи Минздрава России Роман Сафронов объяснил причины появления проблем с созданием Единой государственной информационной системы здравоохранения (ЕГИСЗ).

По словам Романа Сафронова, цели, поставленные в ходе программы информатизации здравоохранения, в основном выполнены, но на тотальную информатизацию выделенных средств недостаточно. Одной из существенных проблем он назвал то, что ИТ-компании, внедрявшие в регионах компоненты ЕГИСЗ, оказались не готовы к долгосрочному сотрудничеству.

Значительная часть компаний, с которыми работал Минздрав, — это небольшие организации, обслуживающие не более десяти некрупных медучреждений. Роман Сафронов отметил, что как только закончилось целевое федеральное финансирование, и медучреждениям понадобилась помощь в отработке технологий, большинство компаний ушло из сферы здравоохранения, некоторые  в принципе прекратили свое существование и сейчас находятся в поиске инвесторов.

Клетки сперматозоидов ранней фазы развития можно создать из кожи мужчин, страдающих бесплодием, показало новое исследование американских ученых из университета штата Монтана.

В исследовании приняли участие трое мужчин, у которых отсутствовали некоторые части ДНК Y-хромосомы. Данная генетическая особенность приводила к снижению формирования сперматозоидов. Специалисты провели у мужчин забор фибробластов – клеток соединительной ткани кожи. Эти клетки ученые генетически преобразовали в индуцированные плюрипотентные стволовые клетки, которые приобрели свойства эмбриональных стволовых клеток.

For the first time, surgeons have used 3D printing to produce exact models of tumour-containing kidneys, allowing them to simulate surgery prior to the real operation. These models can be personalised to each patient, giving doctors a 3D model of each individual's tumour.

Note: photos and video available see below.

Kidney cancers are the 8th most common cancer affecting adults, accounting for around 3% of all cancers in Europe; In 2012 it was estimated that there would be approximately 84.400 new cases of Kidney cancer with 34,700 deaths. It is usually treated surgically, but the operations can be stressful, and speed and accuracy are essential.

Sooriakumaran P.^l, Nyberg T.2, Akre 0.³, Carlsson S.³, Haendler L.³, Steineck G.², Wiklund P.³

^lUniversity of Oxford, Nuffield Dept, of Surgical Sciences, Oxford, United Kingdom, ²Karolinska Institutet, Dept, of Clinical Cancer Epidemiology, Stockholm, Sweden, ³Karolinska Institutet, Dept, of Molecular Medicine & Surgery, Stockholm, Sweden

INTRODUCTION & OBJECTIVES: Standard management for men with advanced prostate cancer is androgen deprivation therapy (ADT) alone. In other malignancies, such as renal and ovarian cancer, there is evidence that treatment of the primary tumour might reduce progression of metastatic disease and lead to improved survival. Our objective was to evaluate whether radical treatment of the primary tumour in men with advanced prostate cancer improved survival over those managed with ADT alone.

Ohno Y., Ohori М., Nakashima J., Okubo H., Takizawa I., Nakagami Y., Satake N., Yoshioka K., Tachibana M.

Tokyo Medical University, Dept, of Urology, Tokyo, Japan

INTRODUCTION & OBJECTIVES: Recent studies have demonstrated associations among the ABO blood group, risk, and prognosis in various diseases. However, to date, few studies have investigated the prognostic significance of the ABO blood group in prostate cancer. The aim of this study was to investigate the association of the ABO blood group with biochemical recurrence (BCR) after radical prostatectomy (RP).

MATERIAL & METHODS: A total of 555 Japanese patients with T1-3N0M0 prostate cancer who underwent RP at our institution between 2004 and 2010 were studied. No patients received neoadjuvant and/or adjuvant therapy. The associations among the ABO blood group, clinicopathologic factors, and BCR were analysed using univariate and multivariate analyses. Hazard ratio (HR) and 95% confidence interval (Cl) for BCR according to the ABO blood group were calculated.

A man's blood group can affect the chance of a recurrence of prostate cancer after surgery, according to new research, which was presented at the European Association of Urology congress in Stockholm. This is the first time that this relationship has been demonstrated.

Prostate cancer is the most common cancer in men, with huge differences in incidence across Europel. For localised prostate cancer the current "gold standard" treatment is Radical Prostatectomy (RP). However despite apparently successful surgery, approximately 30% of patients experience biochemical recurrence (shown by a rising level of Prostate Specific Antigen, PSA) during long-term follow-up.

This new study, from a team led by Dr Yoshio Ohno of Tokyo Medical University, has shown that patients with blood group О had a significantly decreased risk of cancer recurrence after radical prostatectomy (RP).

Analogic to Offer D&K's BioJet Fusion System With Flex Focus Ultrasound for Precise, Targeted Prostate Biopsies

PEABODY, Mass., April 9, 2014 (GLOBE NEWSWIRE) - Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that it has entered into a distribution agreement with D&K Technologies, developer of the BioJet™ Solution, a revolutionary 3D MRI transrectal ultrasound (TRUS) fusion technology. Analogic will distribute the BioJet system for use with its BK Flex Focus™ ultrasound systems, for assistance during precise, targeted prostate biopsies, in Austria, Belgium, Denmark, Germany, Great Britain, Luxemburg, North America, Sweden Switzerland, and The Netherlands.